Back to Search VC Home Page
Venture Capital Search Engine
search over 1,000 Venture Capital related sites
Keywords about VC:  

Vector Capital

1.Sandra Panem   (100%):
Cross Atlantic Partners Home Overview Investment Focus Investment Criteria Management Team Portfolio Investments Completed Investments Active Investments Home | Overview | Investment Focus | Investment Criteria | Management Team | Portfolio Investments | Completed Investments | Active Investments Sa...
2.Cornerstone Equity Investors, LLC (Press Release)   (57%):
Home VESTCOM/CORNERSTONE MERGER CLOSES WEST CALDWELL, NJ - November 15, 2002 - Vestcom International, Inc. (Nasdaq: VESC ), a leading provider of business communications solutions and marketing services, announced today that the merger transaction with Vector Investment Holdings, Inc. and Vector Mer...
3.KBL Healthcare Ventures - Lumenos Launches Enlightened Approach to Health Care   (57%):
Back to News KBL in the News SPINAL CONCPTS CLOSES $21M ROUND August 10, 2001 Austin-based Spinal Concepts Inc. has closed on a $21 million round of funding through the private sale of preferred stock. Proceeds will be used primarily for working capital, expansion of the company's sales network, and...
4.KBL Healthcare Ventures - Lumenos Launches Enlightened Approach to Health Care   (57%):
Back to News KBL in the News SPINAL CONCPTS CLOSES $21M ROUND August 10, 2001 Austin-based Spinal Concepts Inc. has closed on a $21 million round of funding through the private sale of preferred stock. Proceeds will be used primarily for working capital, expansion of the company's sales network, and...
5.Anthem Capital Management   (47%):
News | Current News Back to News Nucleonics Raises $49.2 Million Series B Round June 20, 2004 Dow Jones & Company MALVERN, PA - Nucleonics Inc., a biotech start-up developing novel RNA interference-based, or RNAi, therapies, announced that it has raised $49.2 million in Series B financing. The ...
6.Acorda :: Board of Directors   (46%):
Ron Cohen, M.D. Standish M. Fleming, Forward Ventures John Friedman, Easton Hunt Capital Partners Sandra Panem, Ph.D., Cross Atlantic Partners Barclay Phillips, Vector Fund Management Mark R. E. Pinney, M.B.A., C.F.A., M.Sc. Steven M. Rauscher, Oscient Pharmaceuticals Michael Steinmetz, Ph.D., MPM ...
7.Columbia Strategy LLC   (45%):
Overview Portfolio vs. Company OVI FAQ OVI Demo OVI for a Portfolio vs. Companies OVI is effective at both the portfolio level and at the individual company level. The portfolio level view is created through an aggregated detailed understanding of each company. The relative fit of each company for t...
8.Cinven - Sector focus   (45%):
function SubmitSearch(searchbutton) { document.searchform.searchbutton.value = searchbutton; document.searchform.submit(); } document.write(" "); function displaylanguage() { if(document.all) { document.all.langmenu.style.visibility = "visible"; } else if(document.getElementById) { document.getEleme...
9.Acorda :: Current Investors   (45%):
Acorda Therapeutics is a privately held biotechnology company devoted to developing therapies for individuals with spinal cord injury, multiple sclerosis, and related disorders of the nervous system. Since its inception in 1995, Acorda has raised over $140 million through a combination of individua...
10.Venture capital alliances - syndicate firms from ARCH Venture Partners   (45%):
ARCH works with many other venture capital firms and institutional investors who serve as limited partners, co-investors, and sources of feedback for new company ideas. The following is a partial list of companies that have co-invested in ARCH portfolio companies as part of a syndicate. 3M Corporati...
11.Craig N. Johnson   (41%):
Craig N. Johnson Craig N. Johnson is an Advisory Director and a former Managing Director of Glenthorne Capital, Inc. Mr. Johnson joined Glenthorne Capital in 1994 with thirteen years of executive experience in the shipping industry. Between 1979 and 1989, Mr. Johnson served as President and later C...
12.Scott Burri   (41%):
Doug Broyles has played a leading role in the emergence of a number of California-based technology companies during his career ranging from Engineering Manager to Chief Executive Officer. In his early career, he helped found International Memories, Onyx Systems, and Zilog. He was a major contributor...
13.JMP Securities   (37%):
> Senior Management > News > Fact Sheet > Careers > Business Continuity > Contact Us Charles C. Duncan, Ph.D. Managing Director Senior Analyst, Biotechnology Charles Duncan joined JMP Securities LLC in November 2002 as a Managing Director and Senior Analyst covering biotechnology. ...
14.Delphi Ventures   (35%):
Archived Press Releases 10/17/2000 Cellomics Raises $30M Privately While Waiting To Complete IPO By Brady Huggett Staff Writer of BioWorld Cellomics Inc. completed a $30 million private placement of Series C preferred stock, while another day passed since it filed for an initial public offering in t...
15.Venture Capital Funds Portfolio Provided by a Leading Venture Capital Firm   (35%):
Expertise Portfolio Team About Us News Life Sciences Networks Semiconductors/Computing Software Exits Portfolio Company Services Life Sciences Portfolio Companies Anaborex Anaborex is an early stage biotechnology company focused on metabolic disease. Founded by Scripps researchers the company is tar...
16.Advent International: IPOs   (34%):
Advent International has an outstanding track record of bringing companies to public markets. To date, over 130 of our portfolio companies have completed IPOs on 20 stock exchanges in North America, Europe, Asia and Latin America. We have also helped companies raise nearly $3bn in high-yield debt in...
17.Gunderson Dettmer, Transactions and Clients   (33%):
Investors Represented In Investment Transactions Representative Investment Banking Clients Representative Private Technology Clients Representative Public Technology Clients Representative Medical Device/Life Science Clients Venture Funds For Which The Firm Serves As General Counsel Investors Repre...
18.BLUEPRINT VENTURES   (32%):
The Blueprint Ventures investment team manages approximately $200 million in committed capital with extensive experience in technology investing and company building. Our current portfolio is listed below. AIRTIGHT NETWORKS develops management infrastructure software that enables companies to secure...
19.GrowthWorks -   (32%):
Search Home About Us Venture Capital Our Team Funds Investments News Contact Us Investment Advisors Dealers Investments GrowthWorks Managed Funds Portfolio Company Search GrowthWorks * managed funds invest in entrepreneurial companies across Canada. If you have any difficulties with this search tool...
20.Alta Partners: Our Team   (32%):
Ben joined Alta Partners in 2004 as part of the Alta BioPharma team. Prior to joining Alta, Ben was an Associate in the Healthcare Investment Banking Group at JMP Securities LLC where he worked on a variety of transactions including IPOs, follow-on equity offerings, private placements, and M&A advi...

Page: 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20  

VC Directory: A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   Others